Habitare Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 24-10-2024
- Paid Up Capital ₹ 0.10 M
as on 24-10-2024
- Company Age 5 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 91.52%
(FY 2023)
- Profit 69.61%
(FY 2023)
- Ebitda 280.24%
(FY 2023)
- Net Worth -44.42%
(FY 2023)
- Total Assets 86.10%
(FY 2023)
About Habitare Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Gopal Pathak, Kusum Lata, and Madhur Pathak serve as directors at the Company.
- CIN/LLPIN
U24304HR2019PTC083020
- Company No.
083020
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Oct 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Panchkula, Haryana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Habitare Pharma?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Madhur Pathak  | Director | 14-Oct-2019 | Current |
| Gopal Pathak | Director | 14-Oct-2019 | Current |
| Kusum Lata | Director | 14-Oct-2019 | Current |
Financial Performance of Habitare Pharma.
Habitare Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 91.52% increase. The company also saw a substantial improvement in profitability, with a 69.61% increase in profit. The company's net worth observed a substantial decline by a decrease of 44.42%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Habitare Pharma?
Unlock access to Habitare Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Habitare Pharma?
Unlock and access historical data on people associated with Habitare Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Habitare Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Habitare Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
